lidocaine has been researched along with Erythermalgia in 13 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nociceptive thresholds and supra-threshold pain ratings as well as their reduction upon local injection with lidocaine were compared between healthy subjects and patients with erythromelalgia (EM)." | 9.24 | Pain thresholds, supra-threshold pain and lidocaine sensitivity in patients with erythromelalgia, including the I848Tmutation in Na ( Helås, T; Jönsson, B; Jørum, E; Kleggetveit, IP; Quiding, H; Sagafos, D; Salter, H; Schmelz, M; Segerdahl, M; Zhang, Z, 2017) |
| "Erythromelalgia is a rare, chronic, debilitating condition characterized by redness, warmth, and severe burning pain of the distal extremities." | 5.33 | Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment. ( Guite, JW; Hehir, D; Milovcich, K; Nathan, A; Rose, JB, 2005) |
| "In a family exhibiting severe familial erythermalgia involving 5 members over 3 generations, we treated 4 patients aged 41, 39, 19 and 15 years." | 5.32 | [Treatment of familial erythermalgia with the association of lidocaine and mexiletine]. ( Dupre, D; Guillet, G; Kupfer, I; Legroux-Crespel, E; Misery, L; Sassolas, B, 2003) |
| "Nociceptive thresholds and supra-threshold pain ratings as well as their reduction upon local injection with lidocaine were compared between healthy subjects and patients with erythromelalgia (EM)." | 5.24 | Pain thresholds, supra-threshold pain and lidocaine sensitivity in patients with erythromelalgia, including the I848Tmutation in Na ( Helås, T; Jönsson, B; Jørum, E; Kleggetveit, IP; Quiding, H; Sagafos, D; Salter, H; Schmelz, M; Segerdahl, M; Zhang, Z, 2017) |
| "The treatment of primitive erythermalgia is based on sodium channel blockers such as mexiletine or lidocaine infusions, and on drugs effective on neuropathic pain, such as gabapentin or amitryptiline, in case of erythermalgia associated with small fiber neuropathy." | 1.72 | [Paroxysmal vascular acrosyndromes: Practical approach to diagnosis and management]. ( Senet, P, 2022) |
| "Conclusion: Erythermalgia may involve the face alone, and combinative approaches may be of choice for its treatment." | 1.51 | Erythermalgia Involving the Face Alone: Two Case Reports. ( Huang, YB; Liu, JH; Luo, DQ; Weng, ZS; Wu, HH; Zhao, YK, 2019) |
| "Erythromelalgia has not been well characterized in the pediatric population." | 1.38 | Pediatric erythromelalgia: a retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period. ( Cook-Norris, RH; Cruz-Inigo, AE; Davis, DM; Davis, MD; Sandroni, P; Tollefson, MM, 2012) |
| "Erythromelalgia is a rare disorder characterized by recurrent pain attacks, swelling and redness in the distal extremities." | 1.38 | Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations. ( Berner, R; Creutzfeldt, R; Hufnagel, M; Jakob, A; Staszewski, O; Winterpacht, A, 2012) |
| "Erythromelalgia is a rare, chronic, debilitating condition characterized by redness, warmth, and severe burning pain of the distal extremities." | 1.33 | Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment. ( Guite, JW; Hehir, D; Milovcich, K; Nathan, A; Rose, JB, 2005) |
| "In a family exhibiting severe familial erythermalgia involving 5 members over 3 generations, we treated 4 patients aged 41, 39, 19 and 15 years." | 1.32 | [Treatment of familial erythermalgia with the association of lidocaine and mexiletine]. ( Dupre, D; Guillet, G; Kupfer, I; Legroux-Crespel, E; Misery, L; Sassolas, B, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Senet, P | 1 |
| Helås, T | 1 |
| Sagafos, D | 1 |
| Kleggetveit, IP | 1 |
| Quiding, H | 1 |
| Jönsson, B | 1 |
| Segerdahl, M | 1 |
| Zhang, Z | 1 |
| Salter, H | 1 |
| Schmelz, M | 1 |
| Jørum, E | 1 |
| Liu, JH | 1 |
| Weng, ZS | 1 |
| Luo, DQ | 1 |
| Zhao, YK | 1 |
| Wu, HH | 1 |
| Huang, YB | 1 |
| Cook-Norris, RH | 1 |
| Tollefson, MM | 1 |
| Cruz-Inigo, AE | 1 |
| Sandroni, P | 3 |
| Davis, MD | 4 |
| Davis, DM | 1 |
| Jakob, A | 1 |
| Creutzfeldt, R | 1 |
| Staszewski, O | 1 |
| Winterpacht, A | 1 |
| Berner, R | 1 |
| Hufnagel, M | 1 |
| Elgueta, F | 1 |
| de la Cuadra-Fontaine, JC | 1 |
| Clede, L | 1 |
| Fierro, C | 1 |
| Valderrama, A | 1 |
| Legroux-Crespel, E | 1 |
| Sassolas, B | 1 |
| Guillet, G | 1 |
| Kupfer, I | 1 |
| Dupre, D | 1 |
| Misery, L | 1 |
| Nathan, A | 1 |
| Rose, JB | 1 |
| Guite, JW | 1 |
| Hehir, D | 1 |
| Milovcich, K | 1 |
| Sheets, PL | 1 |
| Jackson, JO | 1 |
| Waxman, SG | 1 |
| Dib-Hajj, SD | 1 |
| Cummins, TR | 1 |
| Rauck, RL | 1 |
| Naveira, F | 1 |
| Speight, KL | 1 |
| Smith, BP | 1 |
| Kuhnert, SM | 1 |
| Phillips, WJ | 1 |
1 trial available for lidocaine and Erythermalgia
| Article | Year |
|---|---|
Pain thresholds, supra-threshold pain and lidocaine sensitivity in patients with erythromelalgia, including the I848Tmutation in Na
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Dose-Response Relationship, Drug; Double-Blind M | 2017 |
12 other studies available for lidocaine and Erythermalgia
| Article | Year |
|---|---|
[Paroxysmal vascular acrosyndromes: Practical approach to diagnosis and management].
Topics: Antibodies, Antinuclear; Aspirin; Calcium Channel Blockers; Erythromelalgia; Gabapentin; Humans; Ilo | 2022 |
Erythermalgia Involving the Face Alone: Two Case Reports.
Topics: Erythromelalgia; Female; Humans; Lidocaine; Male; Middle Aged; Pain; Skin | 2019 |
Pediatric erythromelalgia: a retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period.
Topics: Adolescent; Anesthetics, Local; Cellulitis; Child; Child, Preschool; Comorbidity; Disease Progressio | 2012 |
Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
Topics: Administration, Oral; Amines; Analgesics; Child; Cyclohexanecarboxylic Acids; Diagnosis, Differentia | 2012 |
Erythromelagia: a rare and hard-to-treat condition: a 9-year-old boy responsive to intravenous lidocaine and oral mexilitene.
Topics: Administration, Intravenous; Administration, Oral; Child; Erythromelalgia; Humans; Lidocaine; Male; | 2013 |
[Treatment of familial erythermalgia with the association of lidocaine and mexiletine].
Topics: Administration, Oral; Adolescent; Adult; Anesthetics, Local; Dose-Response Relationship, Drug; Drug | 2003 |
Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment.
Topics: Administration, Oral; Analgesia, Epidural; Anesthetics, Local; Bupivacaine; Child; Erythromelalgia; | 2005 |
Lidocaine patch for pain of erythromelalgia: follow-up of 34 patients.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Erythromelalgia; Female; Follow-Up Studies; Humans; Lid | 2005 |
A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
Topics: Action Potentials; Anesthetics, Local; Binding Sites; Cell Line; Computer Simulation; Dose-Response | 2007 |
Refractory idiopathic erythromelalgia.
Topics: Adolescent; Analgesia, Epidural; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Anes | 1996 |
Lidocaine and mexiletine therapy for erythromelalgia.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Erythromelalgia; Follow-Up Studies; Humans; | 1999 |
Lidocaine patch for pain of erythromelalgia.
Topics: Administration, Cutaneous; Adolescent; Delayed-Action Preparations; Erythromelalgia; Female; Follow- | 2002 |